Clinical Trial Update: Isatuximab in Combination With Rd Compared to Rd in Elderly Patients (Aged ≥70 Years) With NDMM [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating Isatuximab plus lenalidomide-dexamethasone (Rd) versus Rd in elderly patients (age 70 and older) with newly diagnosed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Isatuximab (Sarclisa) (isatuximab)
• Revlimid (lenalidomide)

Snippet

Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie | Conditions: Newly Diagnosed Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING